As one of the largest medical genetics centers in the United States, we conduct pioneering research to identify the genetic susceptibilities--or predispositions-- of many diseases, including cancer. Ayasdi has already helped us glean new insights that will lead to breakthrough drug discoveries.
The Ayasdi software will be at the center of Citi’s Data Center of Excellence. By automating the data-to-value process, Citi will be able to reduce the time to insights, saving them and their customers millions of dollars.
Mercy is committed to using advanced technology to transform healthcare. Working with Ayasdi, we are taking a powerful new approach to care pathways, using data as never before to deliver the transformative health experience that Mercy strives to provide every day.
Ayasdi is collaborating with this global technology powerhouse helping them to accelerate insight discovery from their most challenging and complex problems.
Ayasdi is partnered with this leading global security and aerospace company to uncover insights from complex, multi-attribute program performance data – previously hidden or overlooked by conventional analytics.
Ayasdi is working with this global healthcare company and leader in diabetes care to expedite drug discovery and craft precise treatment paths.
"Intermountain has led the industry when it comes to understanding and managing clinical variation. We have been impressed by Ayasdi’s technology and are optimistic for the impact this could have on our mission of helping people live the healthiest lives possible."
Chief Data Officer, Intermountain Healthcare
"We're excited by Ayasdi's unique capability to let users find insights automatically from large, complex data sets. Their ability to abstract away complexity thereby making powerful machine learning tools accessible to ordinary business users is particularly promising."
Managing Director, Citi
"Mercy is committed to using advanced technology to transform healthcare. Working with Ayasdi, we are taking a powerful new approach to care pathways, using data as never before to deliver the transformative health experience that Mercy strives to provide every day."
Senior Vice President, Operations, Mercy
"Traumatic brain injury remains a major cause of death and disability. Using Ayasdi’s solution we identified distinct groups within the patients enabling us to tailor effective treatment that increases survival rate. This is a major breakthrough in TBI diagnosis and treatment!"
Assistant Adjunct Professor of Neurological Surgery, UCSF Medical Center
"Ayasdi's use of Topological Data Analysis (TDA) is ground-breaking, and Ayasdi's technology makes it easy for anyone to mine and discover insights in large, multi-dimensional data sets to drive rapid innovation in clinical trials and drug discovery."
Research Scientist, Bavarian Nordic